Maze Therapeutics, Inc.
MAZE
$25.56
-$0.87-3.29%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/17/2025
-
MarketBeat
5/14/2026
-
TipRanks Financial Blog
5/14/2026
-
TipRanks Financial Blog
5/14/2026
-
Simply Wall St
5/13/2026
-
TipRanks Financial Blog
5/13/2026
-
TipRanks Financial Blog
5/12/2026
-
Zacks Investment Research
5/12/2026
-
Zacks Investment Research
5/12/2026
-
Globe Newswire
5/11/2026
-
Simply Wall St
5/11/2026
-
The Cerbat Gem
5/7/2026
-
Nasdaq News: Markets
5/7/2026
-
Yahoo! Finance: News
5/7/2026
-
Fool.com Headlines
5/4/2026
-
MarketBeat
5/1/2026
-
MarketBeat
5/1/2026
-
ETF Channel
4/29/2026
-
Simply Wall St
4/26/2026
-
Yahoo! Finance: News
4/25/2026
-
Simply Wall St
4/25/2026
-
Insider Monkey
4/22/2026
-
TipRanks Financial Blog
4/22/2026
-
MarketBeat
4/22/2026
-
Seeking Alpha - Healthcare
4/22/2026
-
SeekingAlpha.com: All News
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 850 5070
Address
171 Oyster Point Blvd
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead...
more